Comparing outcomes of transcatheter tricuspid valve replacement and medical therapy for symptomatic severe tricuspid regurgitation: a retrospective study
The utilization of LuX-Valve in TTVR effectively improves TR and is associated with lower rates of major adverse events, HHF and all-cause mortality. The TRI-SCORE may help identify higher-benefit patients with TR from TTVR. Clinical trial registration ClinicalTrials.gov Protocol Registration System (NCT02917980).
Authors
- Jian Yang (ORCID: https://orcid.org/0000-0003-2059-1912)
- Fanglin Lu (ORCID: https://orcid.org/0000-0002-8633-8955)
- Mengen Zhai
- Yiwei Wang
- Ping Jin (ORCID: https://orcid.org/0000-0003-2330-005X)
- Xin Meng
- Yang Liu (ORCID: https://orcid.org/0000-0002-7240-1546)
Institutions
- Shanghai Chest Hospital (CN)
- Shanghai First People's Hospital (CN)
- Xijing Hospital (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1186/s40001-024-01947-9
- Citations
- 10
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.02
Funders
- National Natural Science Foundation of China